Sosimerasib is an orally active KRASG12C inhibitor. Sosimerasib exerts functional inhibitory effects on KRASG12C mutant proteins. Sosimerasib can be used in research related to non-small cell lung cancer[1].
Molecular Weight:
688.19
Purity:
98.6300
CAS Number:
[2839563-01-6]
Formula:
C36H39ClFN7O4
Target:
Ras
Application Notes:
MCE Product type: Reference compound
* VAT and and shipping costs not included. Errors and price changes excepted